In a preclinical setting, lncRNAs have been suggested as potential diagnostic or prognostic biomarkers affecting a variety of tissues including the heart (MALAT1), reproductive system (H19), muscle (linc‐MD1), and several cancer types (MALAT1, H19, MEG3, HOTAIR) (reviewed in 81, 82). This evidence concerns the gene H19 and cancer.